未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer Bar, Yael; Bar, Kfir; Feldman, Didi; Dror, Judith Ben-; Shahoha, Meishar; Lerner, Shir; Shachar, Shlomit Strulov; Weiss-Meilik, Ahuva; Dershowitz, Nachum; Wolf, Ido; Sonnenblick, Amir 分享 收藏
MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease Jung, Kyung Hae; Im, Seock-Ah; Yardley, Denise; Hurvitz, Sara; Lee, Keun Seok; Sonnenblick, Amir; Shachar, Shlomit; Tan, Antoinette; Comen, Elizabeth; Gal-Yam, Einav; Brufsky, Adam; Rugo, Hope; Zhu, Jing; DuPree, Kelly; Breton, Vanessa; Young, Fiona; Schwab, Richard; Cha, Edward; Telli, Melinda 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry Shachar, Shlomit S.; Leviov, Michelle; Yerushalmi, Rinat; Drumea, Karen; Tokar, Margarita; Soussan-Gutman, Lior; Bareket-Samish, Avital; Sonnenblick, Amir; Ben-Baruch, Noa; Evron, Ella; Gal-Yam, Einav Nili; Paluch-Shimon, Shani; Bar-Sela, Gil; Goldvaser, Hadar; Stemmer, Salomon M. 分享 收藏
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer Waissengrin, B.; Zahavi, T.; Salmon-Divon, M.; Goldberg, A.; Wolf, I; Rubinek, T.; Winkler, T.; Farkash, O.; Grinshpun, A.; Zubkov, A.; Khatib, M.; Shachar, S. S.; Keren, N.; Carmi-Levy, I; Ben-David, U.; Sonnenblick, A. 分享 收藏
The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study Shachar, Shlomit S.; Bar-Sela, Gil; Peer, Avivit; Moskovitz, Mor Tal; Bareket-Samish, Avital; Epstein, Jessica; Wollner, Mira; Shafran, Itamar; Boukal, Amit; Williams, Grant R. 分享 收藏
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews 埃塞俄比亚犹太人的常见创始人BRCA2致病变异和乳腺癌特征 Lieberman, S.; Chen-Shtoyerman, R.; Levi, Z.; Shkedi-Rafid, S.; Zuckerman, S.; Bernstein-Molho, R.; Levi, G. Reznick; Shachar, S. S.; Flugelman, A.; Libman, V.; Kedar, I.; Naftaly-Nathan, S.; Lagovsky, I.; Peretz, T.; Karminsky, N.; Carmi, S.; Levy-Lahad, E.; Goldberg, Y. 分享 收藏
分享 收藏
Differences in Recurrence Score (RS) results between primary and second primary breast cancer (BC): Exploratory analysis of the Clalit Health Services (CHS) registry Shachar, Shlomit Strulov; Leviov, Michelle; Yerushalmi, Rinat; Drumea, Karen; Tokar, Margarita; Soussan-Gutman, Lior; Bareket-Samish, Avital; Sonnenblick, Amir; Ben-Baruch, Noa Efrat; Paluch-Shimon, Shani; Bar Sela, Gil; Stemmer, Salomon M. 分享 收藏
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer 接受早期乳腺癌化疗的黑人和白人女性患者报告的治疗毒性和不良事件 Nyrop, K. A.; Damone, E. M.; Deal, A. M.; Wheeler, S. B.; Charlot, M.; Reeve, B. B.; Basch, E.; Shachar, S. S.; Carey, L. A.; Reeder-Hayes, K. E.; Dees, E. C.; Jolly, T. A.; Kimmick, G. G.; Karuturi, M. S.; Reinbolt, R. E.; Speca, J. C.; Wood, W. A.; Muss, H. B. 分享 收藏
Phase Ib/II open-label, randomized evaluation of second- or third-line (2L/3L) atezolizumab (atezo) plus entinostat (entino) in MORPHEUS-HR plus breast cancer (M-HR plus BC) Sonnenblick, A.; Im, S-A.; Lee, K. S.; Tan, A.; Telli, M.; Shachar, S. Strulov; Tchaleu, F. Bene; Cha, E.; DuPree, K.; Nikanjam, M.; Shemesh, C.; Xu, J.; Zhang, X.; Zhu, J.; Rugo, H. S. 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
